HPV vaccine acceptance among mid-adult women

Daron G. Ferris, Jennifer L. Waller, Ashley Owen, Jozette Smith

Research output: Contribution to journalArticlepeer-review

26 Scopus citations


Objective: To determine correlates of human papillomavirus (HPV) vaccine acceptance in mid-adult women. Methods: A convenience sample of 472 mid-adult women completed a 2-part, 69-item survey that included demographic, knowledge, and behavioral variables as potential correlates of vaccine acceptance. Univariable and multivariable logistic regression models were used to identify correlates for vaccine acceptance. Results: Mid-adult women who received the HPV vaccine were more likely to be younger than 55 years (P < .001); have had an abnormal Papanicolaou test (odds ratio [OR], 2.15; 95% CI, 1.18-3.92); understand that HPV causes cervical cancer (OR, 2.39; 95% CI, 1.08-5.30); feel at risk for HPV infection (OR, 2.14; 95% CI, 1.00-4.57), and feel it is important for their partner (OR, 25.20; 95% CI, 9.66-65.72) and children (OR, 3.54; CI, 0.51-24.56) to get the HPV vaccine. Monogamous mid-adult women (OR, 0.46; 95% CI, 0.21-1.00); women who did not want any vaccines (OR, 0.26; 95% CI, 0.07-0.92); and women who felt it was too late to get the vaccine (OR, 0.18; 95% CI, 0.08-0.44) were less likely to want the HPV vaccine. Conclusions: These clinical predictors of HPV vaccine acceptance will help clinicians recognize midadult women who may be more receptive to vaccination.

Original languageEnglish (US)
Pages (from-to)31-37
Number of pages7
JournalJournal of the American Board of Family Medicine
Issue number1
StatePublished - Jan 2008
Externally publishedYes

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Family Practice


Dive into the research topics of 'HPV vaccine acceptance among mid-adult women'. Together they form a unique fingerprint.

Cite this